Johns Hopkins HIV Guide
Voriconazole
INDICATIONS
FDA
FDA
- Voriconazole is FDA approved for the following indications in adults and pediatrics ≥ 2 years of age:
- Invasive aspergillosis
- Serious infections caused by Scedosporium apiospermum (Pseudallescheria boydii) and Fusarium spp. (including F. solani) in patients intolerant of, or refractory to, other therapies.
- Esophageal candidiasis
- Candidemia in non-neutropenic patients and other deep tissue Candida infections
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Prophylaxis of invasive aspergillosis and disseminated candidiasis in severely immunocompromised hosts
- Based on in-vitro data and limited clinical experience, voriconazole may be effective for infections due to certain dematiaceous fungi (C. immitis)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 8, 2022
Citation
Avdic, Edina. "Voriconazole." Johns Hopkins HIV Guide, 2022. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545220/all/Voriconazole.
Avdic E. Voriconazole. Johns Hopkins HIV Guide. 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545220/all/Voriconazole. Accessed June 2, 2023.
Avdic, E. (2022). Voriconazole. In Johns Hopkins HIV Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545220/all/Voriconazole
Avdic E. Voriconazole [Internet]. In: Johns Hopkins HIV Guide. ; 2022. [cited 2023 June 02]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545220/all/Voriconazole.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Voriconazole
ID - 545220
A1 - Avdic,Edina,Pharm.D.
Y1 - 2022/01/08/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545220/all/Voriconazole
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
